Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 1,000 shares at $108.51 ($110K) on 2019-05-31, disclosed to the SEC on 2019-05-31.
Seasonal purchase ($110k) by Director — this insider has traded LGND in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $111.01 | 250 | $28K | 25.3% |
| 2 | $110.01 | 250 | $28K | 25.1% |
| 3 | $108.51 | 500 | $54K | 49.5% |
| Total | $109.51 avg | 1,000 | $110K | 100% |
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |